Article

Knowledge Graph-Guided Identification of Multiple Sclerosis and Therapeutic Trend Analysis: Real-World Evidence from Two Large Healthcare Systems

2025-11-14

Abstract excerpt

<h4>Background</h4> The multiple sclerosis (MS) therapeutic landscape has evolved over time. <h4>Objective</h4> We conducted a knowledge graph-guided analysis of MS-specific disease-modifying therapy (DMT) prescription trends using longitudinal real-world clinical data. <h4>Methods</h4> We utilized registry-linked electronic health records (EHR) data from two large independent healthcare systems encompassing bo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e1284f8-db19-5deb-8ef4-27f1879bb0bf
DOI: 10.1101/2025.11.12.25340116

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Knowledge Graph-Guided Identification of Multiple Sclerosis and Therapeutic Trend Analysis: Real-World Evidence from Two Large Healthcare SystemsDOI 10.1101/2025.11.12.25340116Read

Ocrelizumab versus Natalizumab in Relapsing-Remitting Multiple Sclerosis: A Registry-Linked Electronic Health Records StudySemantic proximity Read

The Austrian MS Database and the Austrian MS Cohort – a national effort towards data harmonization and prospective data collectionSemantic proximity Read

Unraveling the Co-Morbidity between COVID-19 and Neurodegenerative Diseases Through Multi-scale Graph Analysis: A Systematic Investigation of Biological Databases and Text MiningSemantic proximity Read

Detecting multiple sclerosis disease activity and progression in progress notes from electronic medical records using natural language processing and machine learningSemantic proximity Read

Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation.Semantic proximity Read

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read

BRDKRM: An Explainable Framework for Disease Modifying Drug IdentificationSemantic proximity Read

Phenotyping Healthcare Use 2-3 Decades Before the First Multiple Sclerosis Demyelinating Event.Semantic proximity Read

A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.Semantic proximity Read

Sequence Analysis to Phenotype Health Care Patterns in Adults With Musculoskeletal Conditions Using Primary Care Electronic Health Records.Semantic proximity Read

Increased Rate of Hospitalisation for COVID-19 Amongst Rituximab Treated Multiple Sclerosis Patients: A Study of the Swedish MS RegistrySemantic proximity Read